GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast A/S (XSWX:COLOB) » Definitions » Cyclically Adjusted PS Ratio

Coloplast A/S (XSWX:COLOB) Cyclically Adjusted PS Ratio : (As of Jun. 25, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Coloplast A/S Cyclically Adjusted PS Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PS Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Coloplast A/S Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Coloplast A/S's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast A/S Cyclically Adjusted PS Ratio Chart

Coloplast A/S Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.75 14.58 13.55 8.96 8.09

Coloplast A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.03 9.43 8.09 8.28 9.74

Competitive Comparison of Coloplast A/S's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, Coloplast A/S's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast A/S's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast A/S's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Coloplast A/S's Cyclically Adjusted PS Ratio falls into.



Coloplast A/S Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Coloplast A/S's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Coloplast A/S's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=4.018/118.4000*118.4000
=4.018

Current CPI (Mar. 2024) = 118.4000.

Coloplast A/S Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 2.396 99.700 2.845
201409 2.470 99.700 2.933
201412 2.503 99.400 2.981
201503 2.296 100.200 2.713
201506 2.325 100.300 2.745
201509 2.504 100.200 2.959
201512 2.490 99.800 2.954
201603 2.481 100.200 2.932
201606 2.539 100.600 2.988
201609 2.589 100.200 3.059
201612 2.559 100.300 3.021
201703 2.629 101.200 3.076
201706 2.695 101.200 3.153
201709 2.877 101.800 3.346
201712 2.919 101.300 3.412
201803 2.984 101.700 3.474
201806 3.092 102.300 3.579
201809 3.020 102.400 3.492
201812 3.073 102.100 3.564
201903 3.121 102.900 3.591
201906 3.230 102.900 3.717
201909 3.163 102.900 3.639
201912 3.229 102.900 3.715
202003 3.217 103.300 3.687
202006 2.974 103.200 3.412
202009 3.121 103.500 3.570
202012 3.236 103.400 3.705
202103 3.317 104.300 3.765
202106 3.334 105.000 3.759
202109 3.493 105.800 3.909
202112 3.392 106.600 3.767
202203 3.555 109.900 3.830
202206 3.789 113.600 3.949
202209 3.697 116.400 3.761
202212 3.813 115.900 3.895
202303 3.800 117.300 3.836
202306 3.770 116.400 3.835
202309 3.775 117.400 3.807
202312 3.937 116.700 3.994
202403 4.018 118.400 4.018

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Coloplast A/S  (XSWX:COLOB) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Coloplast A/S Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Coloplast A/S's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast A/S (XSWX:COLOB) Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast A/S (XSWX:COLOB) Headlines

No Headlines